NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

flipper44,

I know you are well aware of NWBO's motivations with regard to maturation of OS. I was just adding an Amen of sorts to your comment about that in the other post. PFS is plenty mature and I would suppose the expected journal article might bring this up. If multiple types of analysis on this board have provided evidence of strong results with fewer data points than what NWBO has I am sure that NWBO can come up with even stronger evidence with what they have. If OS is to remain blinded then I believe what is to be reported on using current data would be considered an interim analysis. If there was an earlier look I would assume any ignored recommendation by the DMC to halt for efficacy based on PFS, in consideration of OS, would also be shared. Best wishes.